Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
|Articles|August 9, 2012
LycoRed Earns European Patents for Tomato Complex
Lyc-O-Mato is a proprietary composition of lycopene and other compounds found in tomatoes.
Advertisement
Premix and tomato ingredients specialist LycoRed Ltd. (Beer Sheva, Israel) has secured European patents for its
Lyc-O-Mato is an oleoresin intended for support against free-radical damage, environmental stress, and sun exposure. European patents will set the stage for the ingredient’s Novel Foods approval and an E number for food additive use. Lycored already holds similar patents for the ingredient in the United States, where it is GRAS-affirmed and approved as a color additive.
“Our Lyc-O-Mato contains a specific proprietary natural composition of tomato lycopene and other tomato phytonutrients, including phytoene, phytofluene, tocopherols, phytosterols, and beta-carotene, as opposed to other lycopene products available currently on the market,” says Yoav Blatt, chief technology officer for Lycored.
Advertisement
Related to this article
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Navigating Supplement Ingredients and Claims Regulations in Europe, the US, and Canada
2
CoreFX Launches CreaSHLD-IN Shielded Creatine at SupplySide Global 2026
3
Study of SRI-81 Shatavari Reports Sexual Function Gains Versus Placebo in Women
4
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
5